Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Geriatric Population and Increasing Prevalence of Chronic Diseases
4.2.2 Increasing Importance and Awareness of Point-of-care Testing
4.2.3 Rising Technological Advancements in Clinical Chemistry Analyzer
4.3 Market Restraints
4.3.1 Lack of Trained and Qualified Professionals
4.3.2 High Cost
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Analyzers
5.1.2 Reagents
5.1.3 Others
5.2 By Types of Test
5.2.1 Liver Panels
5.2.2 Electrolyte Panels
5.2.3 Thyroid Function Panels
5.2.4 Lipid Profiles
5.2.5 Others
5.3 By End User
5.3.1 Hospital
5.3.2 Diagnostic Laboratories
5.3.3 Academic Institutes
5.3.4 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Danaher Corporation (Beckman Coulter, Inc.)
6.1.3 Elitech Group
6.1.4 F. Hoffmann-La Roche Ltd.
6.1.5 Horiba, Ltd.
6.1.6 Johnson & Johnson
6.1.7 Mindray Medical International Limited
6.1.8 Siemens Healthcare Private Limited
6.1.9 Sysmex Corporation
6.1.10 Thermo Fisher Scientific Inc.


7 MARKET OPPORTUNITIES AND FUTURE TRENDS